Hippocratic AI is kicking off 2025 with a bang. The startup, which is building a large language model specifically for healthcare use cases, banked a $141 million series B financing round only nine months after its series A round. The latest funding propels Hippocratic AI’s valuation to $1.64 billion, launching it into “unicorn” status, according to executives. The company is using artificial intelligence to close the gap on the worldwide shortage on healthcare staffing. Venture capital firm Kleiner Perkins led the round. General Catalyst and Andreessen Horowitz (a16z) also backed the series B round along with other existing investors Nvidia, Premji, SV Angel, UHS and WellSpan Health, which all participated at or above pro rata, according to the company. Hippocratic AI has received a total of $278 million in funding from investors. The company also rolled out a healthcare AI agent app store to enable clinicians to design and shape AI agents to address patient care and operational challenges.

Full story : Hippocratic AI, which is building an LLM for health care use cases, raised a $141 million Series B at a $1.64 billion valuation, and launches a health care AI agent app store.